Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting

Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting

US Patent 9463255 · Granted Oct 11, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for use in diagnosing and treating melanoma, including metastatic m2021
Compounds with reduced ring size for use in diagnosing and treating melanoma, in2019
Compounds for use in diagnosing and treating melanoma, including metastatic mela2019
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma ta2019
Compounds with reduced ring size for use in diagnosing and treating melanoma, in2018
Compounds with reduced ring size for use in diagnosing and treating melanoma, in2016
Compounds for use in diagnosing and treating melanoma, including metastatic mela2016
Gonadotropin-releasing hormone receptor-targeting peptides and their use to trea2015
Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for u2015
Compounds with reduced ring size for use in diagnosing and treating melanoma, in2015
Compounds and methods for use in diagnosing and treating melanoma, including met2013